Novartis operates businesses with global scale and strong customer ties, focusing on innovative patented medicines and generics.
Our global portfolio of innovative patented medicines includes more than 50 key marketed products, many of which are among the leaders in their therapeutic areas.
Generics Medicines and Biosimilars
Our Sandoz Division is a global leader in generic medicines and biosimilars, offering more than 1,000 different types of high-quality, affordable products across a broad range of therapeutic areas. It pioneers new ways to help people around the world access high-quality medicines.
Our businesses are supported by global organizations with leading capabilities in research, development, manufacturing and business services.
The Novartis Institutes for BioMedical Research (NIBR), with more than 6,000 scientists and physicians worldwide, is the innovation engine of Novartis. NIBR focuses on discovering new drugs that can change the practice of medicine.
The Global Drug Development organization oversees the clinical development of new medicines that early research indicates may be safe and effective.
Novartis Operations is the manufacturing and business services backbone of the company. It includes:
- Novartis Technical Operations, our global manufacturing organization
- Customer & Technology Solutions (CTS) consolidates support services across the company, helping drive efficiency, standardization and simplification.
Novartis Capability Centre in Kuala Lumpur is one of five around the world, and part of the Customer & Technology Solutions organisation, delivers a broad variety of services to the Novartis divisions and organisations worldwide.
Services offered by the Kuala Lumpur team include IT, People & Organization services, FRA Operations, Procurement Services and CONEXTS Services which includes scientific and commercial services.